Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $642M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NGNE | NEUROGENE INC | 1,004,291 | $51.12M | 8.0% | $14.51 | +130.2% | COM | 64135M105 |
| — | ALPINE IMMUNE SCIENCES INC | 1,128,499 | $44.73M | 7.0% | $9.38 | — | COM | 02083G100 |
| URGN | UROGEN PHARMA LTD | 2,620,545 | $39.31M | 6.1% | $16.05 | +1.8% | COM | M96088105 |
| ABVX | ABIVAX SA | 2,488,483 | $35.59M | 5.5% | $12.06 | — | SPONSORED ADS | 00370M103 |
| EOLS | EVOLUS INC | 2,450,000 | $34.3M | 5.3% | $9.65 | +34.6% | COM | 30052C107 |
| PLRX | PLIANT THERAPEUTICS INC | 1,851,864 | $27.59M | 4.3% | $17.57 | -6.1% | COM | 729139105 |
| APGE | APOGEE THERAPEUTICS INC | 400,000 | $26.58M | 4.1% | $22.03 | +98.2% | COM | 03770N101 |
| — | AEROVATE THERAPEUTICS INC | 887,690 | $26.25M | 4.1% | $21.89 | — | COM | 008064107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,335,000 | $23.38M | 3.6% | $19.39 | 0.0% | COM | 92790C104 |
| ANAB | ANAPTYSBIO INC | 976,981 | $22M | 3.4% | $23.39 | +1.2% | COM | 032724106 |
| ESPR | ESPERION THERAPEUTICS INC NE | 8,000,000 | $21.44M | 3.3% | $2.43 | 0.0% | COM | 29664W105 |
| INSM | INSMED INC | 775,585 | $21.04M | 3.3% | $26.50 | +5.6% | COM PAR $.01 | 457669307 |
| ACLX | ARCELLX INC | 300,000 | $20.86M | 3.3% | $58.67 | +8.1% | COMMON STOCK | 03940C100 |
| XENE | XENON PHARMACEUTICALS INC | 456,148 | $19.64M | 3.1% | $24.44 | +88.2% | COM | 98420N105 |
| — | MIND MEDICINE MINDMED INC | 2,000,000 | $18.8M | 2.9% | $9.40 | — | COM NEW | 60255C885 |
| DNTH | DIANTHUS THERAPEUTICS INC | 625,000 | $18.75M | 2.9% | $21.73 | 0.0% | COM | 252828108 |
| OTLK | OUTLOOK THERAPEUTICS INC | 1,480,000 | $17.67M | 2.8% | $8.09 | 0.0% | COM | 69012T305 |
| FOLD | AMICUS THERAPEUTICS INC | 1,495,500 | $17.62M | 2.7% | $12.08 | +5.9% | COM | 03152W109 |
| OCUL | OCULAR THERAPEUTIX INC | 1,728,723 | $15.73M | 2.5% | $5.42 | +30.9% | COM | 67576A100 |
| — | DYNAVAX TECHNOLOGIES CORP | 1,264,920 | $15.7M | 2.4% | $12.41 | — | COM NEW | 268158201 |
| CYTK | CYTOKINETICS INC | 202,202 | $14.18M | 2.2% | $40.16 | +92.6% | COM NEW | 23282W605 |
| — | OPTINOSE INC | 8,786,318 | $12.83M | 2.0% | $1.78 | — | COM | 68404V100 |
| JSPR | JASPER THERAPEUTICS INC | 407,550 | $11.97M | 1.9% | $17.76 | 0.0% | COM NEW | 471871202 |
| — | INTRA-CELLULAR THERAPIES INC | 150,000 | $10.38M | 1.6% | $56.58 | — | COM | 46116X101 |
| — | MERUS N V | 223,288 | $10.05M | 1.6% | $43.46 | — | COM | N5749R100 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,858,735 | $9.814M | 1.5% | $3.78 | +27.1% | COM | 92840H400 |
| TERN | TERNS PHARMACEUTICALS INC | 1,309,975 | $8.593M | 1.3% | $5.81 | +12.4% | COM | 880881107 |
| IMCR | IMMUNOCORE HLDGS PLC | 115,000 | $7.475M | 1.2% | $50.92 | — | ADS | 45258D105 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 1,166,667 | $7.443M | 1.2% | $6.38 | — | SPON ADS | 05280R100 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1,343,628 | $7.121M | 1.1% | $3.70 | +45.6% | COM | 74587V107 |
| ZURA | ZURA BIO LTD | 2,757,740 | $7.087M | 1.1% | $8.03 | -55.9% | CLASS A ORD SHS | G9TY5A101 |
| BBOT | HELIX ACQUISITION CORP II | 500,000 | $5.2M | 0.8% | $10.35 | 0.0% | CL A ORD SHS | G4444H101 |
| SYRE | SPYRE THERAPEUTICS INC | 125,000 | $4.741M | 0.7% | $13.78 | +110.3% | COM NEW | 00773J202 |
| KYTX | KYVERNA THERAPEUTICS INC | 150,000 | $3.726M | 0.6% | $27.84 | 0.0% | COM | 501976104 |
| ARVN | ARVINAS INC | 71,113 | $2.936M | 0.5% | $23.38 | +86.9% | COM | 04335A105 |